4.3 Article

Smoking and worsening disability in multiple sclerosis: A meta-analysis

期刊

ACTA NEUROLOGICA SCANDINAVICA
卷 138, 期 1, 页码 62-69

出版社

WILEY
DOI: 10.1111/ane.12916

关键词

disability; meta-analysis; multiple sclerosis; smoking; systematic review

资金

  1. Biogen-Idec
  2. Merck-Serono
  3. Bayer-Schering
  4. Novartis
  5. Cinnagen
  6. Osveh
  7. Zistdaru
  8. Zahravi
  9. Genzyme
  10. TUMS

向作者/读者索取更多资源

ObjectivesMultiple sclerosis (MS) is a chronic demyelinating disorder affecting young adults. Environmental factors and lifestyle behaviors are pivotal in MS pathophysiology. Smoking has been considered as an important risk factor in MS. Various recent studies have been conducted to measure the role of smoking on worsening disability in patients with MS, thus we intended to systematically assess effect of smoking on evolution of disability in this study. Materials & methodsWe queried MEDLINE, EMBASE and Cochrane Library with following keywords Multiple Sclerosis, Smoking, Tobacco Use, Disability on December 1st 2016. Original articles were included when smoking history was mentioned, disability was measured via expanded disability status scale (EDSS) or multiple sclerosis severity score (MSSS). Studies with insufficient outcome data, non-human, or in other languages than English were excluded. ResultsThrough literature review after duplicate removals, 268 articles were retrieved. A total of 56 articles were screened and 15 articles were assessed for eligibility, finally, eleven articles were included in this systematic review and meta-analysis. Ever smoking was significantly associated with increased EDSS (standardized mean difference (SMD)=0.15, 95% CI=0.01-0.28), but had no significant association with risk of reaching EDSS 4 (HR=1.24, 95% CI=0.89-1.72) or EDSS 6 (HR=1.17, 95% CI=0.88-1.57). Smoking had no effect on MSSS (SMD=0.14, 95% CI=-0.04-0.32) or T2 lesion volume (SMD=0.07, 95% CI=-0.08-0.22). ConclusionsThis meta-analysis showed smoking increased EDSS, insignificant findings were possibly due to the small number of studies, significant differences in methodologies, and variations in reporting of disability outcomes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据